HB-002 / Zhejiang Huahai Pharma  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
HB-002 / Zhejiang Huahai Pharma
NCT03636750: A Study of Injection HB002.1T in Subjects With Solid Tumor

Completed
1
27
RoW
HB002.1T
Huabo Biopharm Co., Ltd.
Solid Tumor
02/20
03/20
NCT04802980: A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor

Recruiting
1
72
RoW
HB002.1T, Oxaliplatin, Capecitabine, Paclitaxel, Gemcitabine, Cisplatin, Carboplatin
Huabo Biopharm Co., Ltd.
Solid Tumor
07/23
09/23

Download Options